OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary reflects strong financial performance with a 15% revenue increase, improved gross margins, and reduced net loss. Adjusted EBITDA also saw a significant rise. The lack of strategic updates and forward-looking statements indicates some uncertainty, but the financial metrics, especially in the pediatric orthopedic market, suggest a positive outlook. Without additional negative insights from the Q&A, the overall sentiment leans towards a positive stock price reaction.
Key Financial Performance
Revenue Revenue for Q1 2026 was $38.5 million, representing a 15% increase year-over-year. This growth was driven by strong sales in the pediatric orthopedic market and successful product launches.
Gross Margin Gross margin for Q1 2026 was 78%, up from 76% in Q1 2025. The improvement was attributed to better operational efficiencies and favorable product mix.
Net Loss Net loss for Q1 2026 was $2.1 million, compared to a net loss of $3.5 million in Q1 2025. The reduction in net loss was due to increased revenue and improved cost management.
Adjusted EBITDA Adjusted EBITDA for Q1 2026 was $5.2 million, a 30% increase year-over-year. This was driven by higher revenue and operational efficiencies.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Forward-Looking Statements: The company's remarks include forward-looking statements that are subject to numerous risks and uncertainties, which could cause actual results to differ materially.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Blackman TD
Caitlin Cronin
Citizens JMP
Cowen Research
Cronin Canaccord
Director Fred
Director Philip
Division Frederick
Division PM
Division Turkaly
EDT afternoon
Fred Hite
Frederick Wise
Gilmartin Group
Group LLC
Incorporated Research
LLC Mathew
LLC Research
Mathew Blackman
Nicolaus Incorporated
PM EDT
Philip Taylor
Securities
Stifel Nicolaus
Taylor Gilmartin
Turkaly Citizens
Wise Stifel
purpose Gilmartin
KIDS Transcript
OrthoPediatrics Corp. (KIDS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Neutral6-8
OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings Call Transcript
Positive4-30
The earnings call summary reflects strong financial performance with a 15% revenue increase, improved gross margins, and reduced net loss. Adjusted EBITDA also saw a significant rise. The lack of strategic updates and forward-looking statements indicates some uncertainty, but the financial metrics, especially in the pediatric orthopedic market, suggest a positive outlook. Without additional negative insights from the Q&A, the overall sentiment leans towards a positive stock price reaction.
Timbercreek Financial Corp. (TF:CA) Q4 2025 Earnings Call Transcript
Unknown2-26
The earnings call summary presents a mixed picture. While there is strong portfolio growth and favorable interest rate conditions, the valuation adjustments and high payout ratio present risks. The Q&A section did not provide additional insights to adjust ratings. The overall sentiment is balanced, with positive operational updates offset by financial risks, leading to a neutral stock price movement prediction.
OrthoPediatrics Corp. (KIDS) Q4 2025 Earnings Call Transcript
Positive2-26
The earnings call summary reveals strong financial performance with a 15% YoY revenue growth, improved gross margin, and a positive net income turnaround. Despite increased operating expenses, cash flow from operations improved. The strategic initiatives and outlook suggest continued growth, particularly in the pediatric orthopedic market. Although there are forward-looking risks, the overall sentiment is positive, supported by optimistic guidance and strong financial results.
KIDS Slides
KIDS Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
